Apicomplexan parasites replicate within a protective organelle called the parasitophorous vacuole (PV). The Toxoplasma gondii PV is filled with a network of tubulated membranes, which are thought to facilitate trafficking of effectors and nutrients. Despite being critical to parasite virulence, there is scant mechanistic understanding of the network's functions. Here, we identify the parasite secreted kinase WNG1 as a critical regulator of tubular membrane biogenesis. WNG1 family members adopt an atypical protein kinase fold lacking the glycine rich ATP-binding loop that is required for catalysis in canonical kinases. Unexpectedly, we find that WNG1 is an active protein kinase that localizes to the PV lumen and phosphorylates PV-resident proteins, several of which are essential for the formation of a functional intravacuolar network. Moreover, we show that WNG1-dependent phosphorylation of these proteins is required for their membrane association, and thus their ability to tubulate membranes. Consequently, WNG1 knockout parasites have an aberrant PV membrane ultrastructure. Collectively, our results describe a unique family of Toxoplasma kinases and implicate phosphorylation of secreted proteins as a mechanism of regulating PV formation during parasite infection.
Introduction
Protein phosphorylation is the most common post-translational modification in eukaryotic cells. The addition and removal of specific phosphates is a key mediator of cellular information processing and signal transduction. Phosphorylation is catalyzed by protein kinases, which form one of the largest families of enzymes in mammals (1) . The interface between an intracellular pathogen and its host cell is a special case in cellular signaling that defines both a pathogen's ability to manipulate its host and the host's ability to respond to and control the pathogen. The parasite Toxoplasma gondii is one of the most successful pathogens in the world, as it can infect virtually any cell type of almost all warmblooded animals, including approximately one third of humans worldwide (2) . Toxoplasma directly manipulates signaling at the host-pathogen interface by secreting a variety of effector proteins (3, 4) , including ~50 protein kinases and pseudokinases (5, 6) . However, the functions of most of these effectors are unknown.
One vital role for these secreted kinases is to maintain the parasite's replicative niche within its host cell. Like many intracellular pathogens, Toxoplasma survives in a specialized membranous organelle called the parasitophorous vacuole (PV). This vacuole is maintained as distinct from host endosomal trafficking, and is protected from fusion with host lysosomes (7) . Disruption of the PV membrane by host immune defenses leads to parasite death (8, 9) , and the parasite has evolved effector molecules that can protect it from such host attacks (10, 11). Far from being an impermeable wall, however, the parasite selectively exports (12) and imports (13, 14) molecules across the PV membrane.
One of the most striking features of the PV is the intravacuolar network (IVN) of membranous tubules of 20-50 nm diameter that appear to bud from the PV membrane into the vacuolar lumen (15). Notably, the inside of the tubules is topologically contiguous with the host cytosol (15). The IVN has been associated with diverse phenomena, including nutrient uptake via trafficking of host-derived vesicles (16, 17) , "ingestion" of soluble host proteins by the parasite (18) , protection from antigen presentation (19) , and a means by which parasite effectors localize to the PV membrane (20) and thus protect it destruction by host immune effectors (21) . The dense granular proteins GRA2 or GRA6 are required for IVN biogenesis and parasites that lack either protein grow in vacuoles without the wellstructured membranous tubules. While IVN-deficient parasites grow normally in in vitro cell culture, they have strongly attenuated virulence in a mouse model of infection (22) .
The PV is thus a complex cellular compartment that mediates sophisticated, multidirectional trafficking, though the molecules that regulate its functions are largely a mystery. Many of the known components of the PV, and of the IVN in particular, are highly phosphorylated after they have been secreted from the parasite (23) . About one third of the Toxoplasma kinome contains signal peptides but lack transmembrane domains, and are thus predicted to be secreted. Most of these kinases belong to a parasite-specific family that includes a number of virulence effectors (24, 25, 10) secreted into the host cytosol from the parasite rhoptries during invasion (26) , and have been dubbed the "rhoptry kinase (ROPK)" family. A previous bioinformatic effort annotated the majority of predicted secreted kinases in Toxoplasma as ROPKs (5) . Notably, vertebrate or ROPK effector kinases localized in the host cytosol cannot access PV-resident proteins on the lumenal side of the PV membrane. However, two members of the ROPK family, ROP21/27, were recently found to localize to a different set of secretory organelles, the dense granules, which secrete into the PV lumen. Because ROP21/27 are expressed mainly during the chronic stage of the parasite (27) , they are unlikely to function in the regulation of processes during the acute stage, such as the biogenesis of the IVN.
In the present work, we identify a specialized family of kinases that lack the glycine-rich loop that is critical for nucleotide-binding in canonical kinases, leading us to name them the With-no-Gly-loop, or WNG, family. These WNG kinases are conserved throughout the coccidian family of parasites to which Toxoplasma belongs and are secreted into the PV. We solved the crystal structure of a family member which demonstrates that the N-lobe of the kinase does indeed lack the structural elements that form the Gly-loop. We found that at least one member of the family, WNG1/ROP35, is catalytically active and we identified a number of proteins associated with the IVN membrane as phosphorylated in a WNG1-dependent manner. Finally, we demonstrated that loss of these phosphorylation sites correlates with aberrant PV ultrastructure, likely due to the loss membrane association of proteins that drive the biogenesis of IVN tubules. Taken together, our data show the WNG family of kinases mediates specialized functions in regulating the proteins that create and maintain the coccidian hostparasite vacuolar interface.
Results

Identification of a divergent family of coccidian secreted kinases that lack the canonical glycine-rich loop
We reasoned that regulatory phosphorylation of PV-resident proteins would most likely be carried out by a conserved resident protein kinase that is secreted from the parasites dense granules. To identify potential PV-resident kinases, we compared the sequences of the predicted secreted kinases in Toxoplasma. We were surprised to find that a small family of parasite kinases appear to completely lack the glycine-rich, or P-loop, that is found in all canonical kinases and is required for binding the ATP in the active site (28, 29) (Supplemental Fig S1a,b) . These kinases include three proteins annotated as ROPKs (ROP33, ROP34, and ROP35), and a pseudokinase, BPK1, that has previously been identified as PV resident and a component of the bradyzoite cyst wall (30) . Phylogenetic analysis 3 gave clear support for these proteins forming a clade that is distinct from canonical protein kinases (Figure 1 ), including the parasite ROPKs. Furthermore, we identified members of this family in every species of coccidian parasite for which genomic sequence is available (Figure 1 and Supplemental  Table S1c ), suggesting that they play an important role in the parasites' pathogenic lifestyle. Notably, the majority of ROPKs are not conserved throughout coccidian parasites, with the exception of the PVresident kinases ROP21/27 (31) . Given the lack of the glycine-rich loop and phylogenetic evidence that indicates that these proteins form a distinct clade, we propose that the family be named the WNG (With-No-Gly-loop) kinases.
WNG kinases are secreted into the parasitophorous vacuole
As noted above, BPK1 has previously been identified as a PV-resident pseudokinase (30) . We thus sought to assess the localization of other WNG kinases, and concentrated on the most divergent members of the family in Toxoplasma: ROP34 and ROP35 ( Figure 1 ). We engineered parasite strains in which the endogenous copies of each of ROP34 and ROP35 were expressed in frame with a 3xHA tag. While both proteins appeared to be secreted into the PV, neither ROP35 nor ROP34 co-localized with the rhoptry marker ROP2 (Figure 2A ). ROP35 co-localized well with the dense granular marker, GRA6, both within the parasites and after secretion into the PV ( Figure 2B ). ROP34 displayed a slightly different localization, in which the secreted protein localized to the basal end of the parasites within a vacuole. In addition, we observed brighter foci of ROP34 within parasites than within the vacuole, suggesting that ROP34 does not accumulate within the PV to the same extent as ROP35. While these data appear inconsistent with reported localization of ROP35 to the parasite PV via rhoptry secretion (32) , we note that the previous report did not colocalize ROP35 with a known rhoptry marker, nor did it analyze endogenously tagged protein, both of which could lead to misinterpretation of the protein's endogenous localization. As the "ROP" designation was originally created to indicate localization rather than function (33) , we propose that the WNG kinases be renamed to avoid confusion with the unrelated ROPK family. Given its high conservation ( Figure 1 and Supplemental  Table S1c ), we propose ROP35 be renamed WNG1, and other family members annotated as in Figure  1 and Supplemental Table S1c .
The crystal structure of TgBPK1 reveals a non-canonical active site that lacks the Gly-loop
While the Gly-loop is thought to be both a critical catalytic and structural element of the protein kinase fold, a number of unusual kinases have been demonstrated to have either adapted a canonical kinase fold to perform a specialized non-catalytic function (34, 35, 11) , or to use an atypical fold and active site to catalyze phosphoryl transfer (36, 37) . We therefore sought structural information to better understand the topology of the WNG kinase fold. While we were unable to crystallize an active WNG kinase, we readily obtained crystals of the Toxoplasma pseudokinase BPK1 (Bradyzoite Pseudokinase 1). We solved the structure of BPK1 to 2.5 Å resolution ( Figure 3A and Table 1 ). Like WNG1, BPK1 is secreted into the lumen of the PV (30), and is a clear member of the WNG family ( Figure 1 ). As such, BPK1 shares both primary identity and predicted secondary structure with other WNG kinases throughout its sequence ( Figure S1a ), indicating that its structure would provide faithful insight into the WNG kinase fold.
The BPK1 structure revealed a divergent kinase fold in which the Gly-loop and the first β-strand that stabilizes it (β1 in PKA nomenclature), have been replaced by a helical extension that packs against the top of the N-lobe of the kinase (Figure 3 ). Remarkably, not only do the WNG kinases lack a Gly-rich primary sequence, but have replaced the structural elements that compose the motif, resulting in a reorganized N-lobe architecture ( Figure 3C ,D). The core of the kinase fold, however, is remarkably well conserved, supporting our phylogenetic data ( Figure 1 ) that suggest the WNG family diverged from a canonical Ser/Thr kinase fold. Two salt bridges help stabilize the BPK1 N-lobe within the pseudoactive site, including the bridge between the conserved αC-helix Glu and VAIK-Lys ( Figure  S3A ). Notably, the lack of the Gly-loop and β1-strand creates an active site that is much more open than that of a canonical kinase, such as PKA ( Figure S3B,C) .
While BPK1 is a confirmed pseudokinase that cannot bind nucleotide (38) , the other WNG kinase family members have conserved the other canonical motifs essential for catalysis ( Figure S1a and Figure 4A , suggesting they may be active. To better understand how the WNG kinases have adapted their active sites to bind nucleotide and catalyze phosphoryl transfer without a Gly-loop, we modeled the WNG1/ROP35 active site using the structure of BPK1 as a template ( Figure 4B ,C). This model, together with analysis of sequence conservation among WNG1/ROP35 orthologs (Supplemental Figure S4 ), confirmed that the core of the canonical active site appears largely conserved ( Figure 4C ).
We expressed and purified the kinase domain of Toxoplasma WNG1/ROP35 and found that it robustly phosphorylated the generic substrate MBP in an in vitro kinase assay. We verified that mutation of each of the canonical motifs that enable catalysis and Mg 2+ /ATP-binding (HRD*, VAIK*, D*FG) resulted in loss of kinase activity ( Figure 4D ). We also identified three notable variations from typical motifs within the active site. First, we noted that while substitution of the Ala in the VAIK motif to a bulkier side chain usually interferes with ATP-binding, WNG family members appear to prefer a Val at this position. Mutation of V344A in WNG1/ROP35 reduced the specific activity of the kinase tõ 20% of wild-type ( Figure 4D ), consistent with a requirement for repositioning the ATP within the WNG active site. Second, we noted that WNG1/ROP35 orthologs have conserved a stretch of basic residues (R312/313 in Toxoplasma) that are placed near where the Gly-loop would lie (Figures 4B,C and S4). We therefore reasoned that the side chains of these residues may form a degenerate Walker A motif-like cap (28) , and help replace the Gly-loop function. Consistent with such a model, both R312A and R313A mutants exhibited reduced specific activity, though R313A showed a much less severe effect than R312A ( Figure 4D ).
Finally, we noted that the WNG kinase Mg 2+ -coordinating DFG motif had an acidic residue (E447 in WNG1) replacing the Gly. As in our BPK1 structure ( Figure S3A ), the WNG1 E447 appears to form a salt-bridge with a conserved basic residue +2 from the VAIK Lys ( Figure 4C ; K348 in WNG1). This substitution is unusual for two reasons. (i) the DFG Gly is thought to be important for the regulation of many kinases, as it enables the peptide backbone to "flip" between two states ("DFG-in" and "DFGout"; (39, 40) ); (ii) the side chain of the Glu would be predicted to point towards the phosphates of the bound nucleotide ( Figure 4C ), and would thus electrostatically clash. We reasoned that a clash may be prevented, however, if the residue was participating in Mg 2+ -coordination, as the Asp in the DFG does. The pseudokinase domain of metazoan RNaseL also has this unusual substitution, in this case, a DFD motif. The crystal structure of RNaseL pseudokinase demonstrated that both acidic residues in the DFD motif participate in Mg 2+ -coordination (41), helping to explain the protein's unusually high affinity (1 μM) for ATP. We therefore tested whether mutation of WNG1/ROP35 E457 to either Gly or Ala would affect its activity, and found that both mutant proteins had severely attenuated activity that was not significantly different from the kinase-dead HRD D437S mutant ( Figure 4D ).
We went on to determine that our recombinantly expressed WNG1 has an in vitro KM,ATP of 520±90 μM ( Figure 4E ), using MBP as a substrate. Given the lack of the Gly-loop, which is a key ATPbinding element, it is unsurprising that this KM,ATP, is higher than the 10-100 μM reported for many canonical kinases (42) . However, the mammalian kinases Src and Akt have reported KM,ATP of approximately 200 μM and 500 μM, respectively (42) , indicating that our value for WNG1/ROP35 is consistent with an active kinase. Furthermore, the PV membrane is permeable to small molecules such as nucleotides (13, 14), and cellular ATP concentrations range between 2-5 mM (43), suggesting that PV nucleotide concentrations are well above that needed for activity with such an affinity for nucleotide.
Taken together, our structural and biochemical data suggest that WNG1/ROP35 and other family members are active protein kinases that have evolved multiple alterations to the active site to compensate for the lack of a Gly-loop. Furthermore, these broad structural changes imply an evolutionary pressure to reshape the protein structure to perform a specialized function.
The intravacuolar network of parasites deficient in WNG1 kinase activity is unstable
We next sought to identify potential functions for the WNG kinases. We chose to concentrate our efforts on WNG1 because it is conserved throughout coccidia ( Figure 1 ), concentrates within the PV lumen ( Figure 2 ), and is important for chronic infection in a mouse model of infection (44) . We used double homologous recombination to knock out the WNG1 locus in the RHΔku80Δhxgprt background (Supplemental Figure S5a ). The resulting RHΔwng1 parasites showed no obvious growth phenotype in normal culture conditions (not shown). We also generated WNG1-complemented strains by knocking a wild-type or kinase-dead (D437S; the HRD motif) copy of WNG1 into the empty Ku80 locus of the RHΔwng1 strain. The kinase was expressed with its native promoter and in-frame with a Cterminal 3xHA. Both the active and kinase-dead complement strains expressed WNG1 at similar levels to the levels in the endogenously tagged parasite strain, and were appropriately localized to the dense granules and IVN (Supplemental Figure S5b) .
To examine the ultrastructure within the vacuoles of parasites with and without active WNG1, we used transmission electron microscopy (TEM). We compared the vacuoles of HFFs that had been infected for 24 hours with either parental, RHΔwng1, or the complemented strains ( Figures 5, S5c) . The IVN is a complex structure of branching membranous tubules that fills a large portion of the PV lumen (45) . As expected, we observed a dense network of tubules filling the lumenal space between the parental parasites ( Figure 5A ). While we did observe regions with IVN tubules in RHΔwng1 vacuoles, they been largely replaced with unusual multilamellar structures containing many 70 -150 nm diameter vesicles within a larger 0.5 -2 μm membrane-delineated object ( Figure 5B ). These multilamellar structures appear much less electron dense than the tubular network, suggesting a lower protein content. Consistent with this observation, the internal vesicles appear to have been lost in some structures ( Figure 5B , S5c), potentially due to reduced crosslinking before plastic embedding. Importantly, we prepared samples from mutant parasite strains in parallel with a parental control. We never observed loss of tubular structures in the parental strains, suggesting that this phenotype is not an artifact of our preparation. While vacuoles of wild-type WNG1 complemented parasites were indistinguishable from the parental, those formed by the kinase-dead complemented strain exhibited the same loss of IVN tubules and its apparent replacement with large multilamellar vesicles ( Figures  5C-D) . These changes were quantified in Figure 5E one or more proteins involved in IVN biogenesis and stability, and that this phosphorylation is required for normal function.
Quantitative phosphoproteomics reveals GRA proteins as candidate substrates of WNG1
To identify potential substrates of WNG1, we compared phosphoproteomes of the parental (WT) and RHΔwng1 strains using stable isotope labeling with amino acids in cell culture (SILAC) quantitative mass spectrometry (MS) based proteomics as previously described (46) . Briefly, we infected human foreskin fibroblasts (HFFs) for 24 h with WT or RHΔwng1 parasites previously grown in either "heavy" (H) or "light" (L) SILAC media. After cell lysis we mixed the samples (H and L) in 1:1 ratio applying forward (Δwng1/WT), reverse (WT/Δwng1) as well as control labeling (WT/WT). This mixing strategy ensures that both systematic and technical errors due to stable isotope labeling can be identified and results in high confidence of MS quantifications. Mixed lysates were then digested with LysC/trypsin and phosphopeptides enriched and fractionated as described in the methods section. We prepared 3 biological replicates for WT vs Δwng1 samples and analyzed quantitative differences in the proteome and phosphoproteome between WT and mutant samples by mass spectrometry. We identified 10,301 phosphosites for both human and Toxoplasma and obtained quantification (H/L ratios) for 8,755 of them. Toxoplasma-specific sites constituted 2,296 (~30%) of all quantified sites ( Supplemental Table S6 ), which is a similar proportion of sites identified in previous studies using intracellular Toxoplasma parasites (23) . In order to identify significantly changing sites between WT and Δwng1 parasites a one sample t-test was performed applying the following parameters: p-value < 0.05 and |log2| fold change > 1 ( Figure 6 ). Furthermore, phosphosite significance was also correlated with the SILAC control sample (WT/WT) and the proteome data to control for differential phosphorylation originating from the technical variation in the system and protein abundance, respectively ( Supplemental Table S6 ). We also identified a number of phosphorylation sites on protein with consistent loss of phosphorylation in RHΔwng1 parasite strains, that however, did not pass the ttest significance test ( Supplemental Table S6 ). However, all phosphorylation sites close to the p-value cutoff are predicted or known secreted proteins, indicating that the p-value may be overly stringent in this case.
We identified 10 proteins in which phosphorylation was significantly reduced between the parental and RHΔwng1 samples ( Figure 6 , Table 2 , and Supplemental Table S6 ). Among these candidate substrates were 6 proteins well-known to be associated with the parasite IVN tubules ( Table 2) , including GRA2 and GRA6, which are essential for IVN biogenesis (45) . Another hit, GRA37, was identified in a recent proteomics analysis of PV membrane proteins, and was found to colocalize with IVN markers (47) . We identified three proteins with WNG1-dependent phosphorylation that have not been previously studied, and are therefore annotated as "hypothetical" in the genomic database (ToxoDB v32 gene models: TGGT1_244530, TGGT1_254000, and TGGT1_267740). We reasoned that if WNG1 is, indeed, a PV-resident kinase, WNG1-dependent phosphorylation should predict PV (and possibly IVN) localization. We therefore engineered strains in which the proteins were endogenously tagged at their C-terminus with a 3xHA epitope. Immunofluorescence revealed that each of these proteins were secreted into the PV, and co-localized with the dense granular and IVN marker GRA6 both within parasites and within the vacuolar lumen ( Figure 7A ). We have thus annotated these three genes as encoding newly described dense granular proteins GRA43, GRA44, GRA45 (Tables 2 and 3 ).
In addition to the phosphosites that were lost in the vacuoles lacking WNG1, we identified 7 sites where phosphorylation was significantly increased in the RHΔwng1 samples over parental (Table 3) . These include 1 site on GRA6, 5 sites on GRA7, and 1 site on TGGT1_244530. The phosphorylated states of GRA6 and GRA7 in cells infected with wild-type parasites are readily distinguishable by SDS-PAGE and western blot (16, 48) . To confirm the changes in phosphorylation of these proteins, we blotted lysates of cells infected with either the parental or RHΔwng1 strains ( Figure 7B ). To demonstrate that these changes were due to the presence of WNG1, and to confirm the requirement of WNG1 kinase activity, we also assessed GRA protein membrane association in the wild-type and kinase dead WNG1 complemented strains ( Figure S5a ). We then analyzed lysates of cells infected with each the above strains by western blot probed with either anti-GRA6 or anti-GRA7 antibody. The slower migrating, phosphorylated band of GRA6 was apparent in both parental and wild-type complemented lysates, but was undetectable in the knockout and kinase-dead complemented lysates ( Figure 7B ). Consistent with complex WNG1-dependent differences in phosphorylation of GRA7, we observed a reduction in the total amount of phosphorylated GRA7 in the knockout and wild-type complemented parasites, but observed other slowly migrating bands, presumably the novel phosphostates listed in Table 3 . Our data thus demonstrate WNG1 is an active, PV-resident kinase that is required for the phosphorylation of proteins associated with the PV-facing leaflet of the IVN membrane.
Given that these candidate WNG1 substrates have been demonstrated to either associate with or integrate into PV membranes (48) (49) (50) (51) (52) (53) , we asked whether WNG1 itself was membrane associated once secreted into the PV. To test this, we mechanically disrupted a human foreskin fibroblast (HFF) monolayer that had been highly infected with WNG1-3xHA parasites. Intact parasites were separated from host and PV membranes by a low speed (2400 g) spin, and the resulting supernatant was further separated by ultracentrifugation. WNG1, like the known integral membrane protein (and putative WNG1 substrate) GRA2, was found largely in the membrane-associated pellet ( Figure 7C ). In parallel, we partitioned an aliquot of the same low speed supernatant with Triton-X-114 (54) . While GRA2 was found entirely in the detergent phase, WNG1 partitioned in the aqueous phase ( Figure 7D ), indicating that it is a soluble protein that is membrane-associated, rather than integrating into the membrane directly. Such a non-integral association of WNG1 with the PV membrane is consistent both with the lack of a predicted transmembrane, amphipathic helix, or other membrane association domain in the WNG1 sequence, and with our ability to purify soluble recombinant protein.
Efficient membrane association of proteins involved in intravacuolar network biogenesis depends on WNG1 kinase activity
The trafficking of IVN-associated proteins is highly unusual. Many GRA proteins integrate amphipathic or transmembrane helices into the IVN membrane, but remain soluble while trafficking through the parasite secretory system (48, 49, 53) , presumably by complexing with an unidentified chaperone. Notably, many of the WNG1-dependent phosphorylation sites are located in predicted helical regions of sequence ( Figure S8A ) that have been shown to be required for GRA membrane association (50, 55) . We therefore reasoned that phosphorylation of substrates by WNG1 may help regulate the switch from soluble to membranous states of IVN-associated GRA proteins. To test this hypothesis, we assessed WNG1 membrane association by comparing fractionated lysates from parental, RHΔwng1, and the kinase-active and kinase-dead complement strains. We prepared 8   251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272  273  274  275  276  277  278  279  280  281   282  283   284  285  286  287  288  289  290  291 samples from 6 independent infections per condition, which were then separated by SDS-PAGE and analyzed by protein immunoblotting using antibodies recognizing various GRA proteins as indicated in Figure 8 . We observed no difference in Triton-X-114 partitioning for any of the strains ( Figure S8B ). We quantified the relative soluble amounts of each protein ( Figure 8B ), which revealed a requirement for WNG1 kinase activity on IVN GRA membrane association. In particular, GRA4, GRA6, and GRA7 exhibited significant reductions in the fraction of protein that was PV membrane-associated in the RHΔwng1 and kinase-dead samples. Notably, the phosphorylated forms of GRA6 and GRA7 are found exclusively in the membrane-associated fractions ( Figure 8A ), and the loss of the phosphorylated states does not appear to result in a concomitant increase in unphosphorylated protein at the membrane. Taken together, our results suggest that WNG1-dependent phosphorylation of the GRA proteins promotes their association and is critical for the proper formation of the IVN.
Discussion
We have identified an unusual family of parasite-specific protein kinases that divergently evolved from a canonical protein kinase fold and have lost the typical Gly-rich loop. We have demonstrated that, in spite of missing a structural element thought to be critical to nucleotide binding and catalytic activity, the WNG kinases can catalyze phosphoryl transfer. Through structural and biochemical analyses, we have delineated subtle changes to the kinase active site that facilitate its catalytic activity. We went on to show that the most conserved member of the family, WNG1/ROP35, is secreted by Toxoplasma into the PV, where it associated with the PV membranes. We found that WNG1 kinase activity is required for the phosphorylation of many of the proteins known to be associated with the IVN membranes. Furthermore, loss of WNG1 kinase activity was correlated with a reduction in membrane association for a subset of the IVN proteins for which there are antibodies available. Finally, we found that parasite vacuoles deficient in catalytically active WNG1 have a substantial reduction in their IVN, suggesting that kinase activity is required for either the efficient formation or stability of the IVN membrane tubules.
The unusual WNG kinase fold raises the question: what may have been the evolutionary pressure that drove the divergence of the WNG family and loss of the Gly-loop? WNG1 is the most conserved member of the family, and appears to preferentially phosphorylate sites on proteins closely associated with the IVN membrane. Moreover, many of the sites we identified are at or near predicted helices ( Figure S8A ) that have been previously implicated in GRA protein interaction with membranes (50, 55, 56) , or, in the case of GRA3, within a predicted coiled-coil. The rearrangement of the WNG active site has resulted in an unusually open active site ( Figure S3B ,C) that may better accommodate such folded or otherwise sterically restricted substrates. The atypical "alpha" family of kinases (57) are also able to phosphorylate helical substrates, such as the coiled-coil domains of myosin heavy chains (58) . The alpha kinases share no detectable sequence homology to canonical protein kinases in spite of their similar overall folds (59, 60) . The active sites of alpha kinases differ in several ways from canonical protein kinases. As with the WNG kinases, the alpha kinases have a more open active site that would accommodate a helical substrate (60) . In any event, a comprehensive understanding of the mechanisms of substrate recognition in atypical kinases such as the WNG and alpha kinase families will require structural studies of kinase:substrate complexes.
Notably, the phosphosites we identified as WNG1-dependent are not detectable in extracellular parasites (23) , indicating that WNG1 phosphorylates its substrates in the PV lumen rather than while 9   293  294  295  296  297  298  299  300  301  302  303   304   305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333 trafficking through the parasite secretory system. Our phosphoproteomics data revealed both phosphosites lost in WNG1 knockout parasites, as well as a smaller number of upregulated sites that were only detectable when WNG1 was missing. These data suggest that another kinase is capable of phosphorylating a subset of sites on the IVN GRA proteins, and its activity may be partially compensating for WNG1 loss. Alternatively, this other kinase activity may be acting in competition with that of WNG1. It is possible that these novel sites are phosphorylated by another member of the WNG family. Regardless, the data we present here are consistent with a role for WNG1-mediated phosphorylation in the regulation of protein-protein and/or protein-membrane interactions of PVresident proteins.
The multilamellar vesicles we observe in vacuoles deficient in WNG1 kinase activity are reminiscent of structures that have been previously observed during the first steps of IVN biogenesis (15). While non-phosphorylated, recombinantly-expressed GRA2 and GRA6 are sufficient to tubulate large unilamellar vesicles in vitro (19) , it is possible that WNG1 kinase activity is required to ensure the efficiency of this process in cells. This may be explained by an apparent paradox that exists in GRA protein trafficking: GRA proteins that are destined to integrate into PV membranes traffic through the parasite secretory system as soluble entities (48) (49) (50) , presumably in complex with an unknown solubilizing protein ( Figure 9 ). Such a switch ensures that the parasite's intracellular and plasma membranes are protected from the tubulating activity of the GRA proteins. Removal of a solubilizing chaperone normally requires energy provided by ATP hydrolysis. There are no known chaperones secreted into the Toxoplasma PV. Consistent with a model in which WNG1 regulates membrane association of a subset of PV GRAs, we observed that each GRA4, GRA6, and GRA7 had were substantially more soluble in the vacuoles of parasites deficient in WNG1 kinase activity. There is thus an intriguing possibility that the ATP used during WNG-mediated phosphorylation is providing the energy to drive membrane insertion of a subset of GRA proteins (Figure 9 ). Such a non-canonical chaperoning mechanism is not without precedent. The mammalian neuropeptide 7B2 solubilizes the prohormone convertase 2 as it traffics to the Golgi (61), where 7B2 is phosphorylated by a resident kinase, resulting in release of the complex (62, 63) .
In spite of decades of study, the Toxoplasma parasitophorous vacuole remains a mysterious organelle. The major function identified for IVN-associated proteins is in IVN biogenesis, as the deletion of either GRA2 or GRA6 results in a complete loss of the structure (45) . Such IVN-deficient parasites have been used to link the IVN to nutrient uptake (16-18) and immune evasion (19, 21) , though the precise mechanisms and roles of the IVN have not been established in these processes. Consistent with the pleiotropic effects of disrupting the IVN, knockout of IVN-associated proteins strongly attenuates parasite virulence (22, 64) . Infection of mice with WNG1 knockout parasites yields a substantially reduced cyst burden (44) , which is consistent with the role we observed for WNG1 in IVN biogenesis and stability and the likely resulting pleiotropic effects on the parasite's biology. Our discovery of potential regulatory phosphorylation may facilitate future work to associate specific GRA protein complexes with their biochemical functions and thus better delineate the roles of the IVN in parasite pathogenesis.
Materials and Methods
Phylogenetic analysis -Protein sequences for the WNG kinases were identified by using custom scripts that iteratively BLAST (65) the ToxoDBv24 collections for Toxoplasma gondii, Neospora   10   335  336  337  338  339  340  341  342  343  344  345  346  347  348  349  350  351  352  353  354  355  356  357  358  359  360  361  362  363  364  365  366  367  368  369  370  371  372  373   374   375 caninum, Sarcocystis neurona, Eimeria spp., Cystoisospora suis, and Cyclospora cayetanensis. Besnoitia besnoiti sequences from the Uniprot nonredundant collection. Multiple sequence alignments were generated by MAFFTv7 (66) , and manually edited as necessary. The maximum likelihood phylogenetic tree and bootstrap analysis (1000 replicates) were estimated using RAxML v8.1.17 (67) , and the resulting tree was annotated using a script based on the jsPhyloSVG package (68) and Inkscape.
PCR and plasmid generation -All PCR was conducted using Phusion polymerase (NEB) using primers listed in Supplemental Table S10 . Constructs were assembled using Gibson master mix (NEB). Point mutations were created by the Phusion mutagenesis protocol.
Parasite culture and transfection -Human foreskin fibroblasts (HFF) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 2 mM glutamine. Toxoplasma tachyzoites were maintained in confluent monolayers of HFF. Epitope-tagged and knockout parasites were generated by transfecting the RHΔku80Δhxgprt strain (69) with 15 μg of linearized plasmid and selecting for HXGPRT expression, as previously described (70) . The loxPflanked HXGPRT selection cassette in knockout parasites was removed by transient transfection with a plasmid overexpressing Cre recombinase, and selecting with 6-thioxanthine. WNG1 complement parasites were created by targeting 3xHA-tagged WNG1 (either wild-type or kinase-dead) driven by its native promoter, together with a bleomycin resistance cassette, to the empty Ku80 locus, and selecting with bleomycin, as previously described (71).
Immunofluorescence -HFF cells were grown on coverslips in 24-well plates until confluent and were infected with parasites. The cells were rinsed twice with phosphate buffered saline (PBS), and were fixed with 4% paraformaldehyde (PFA)/4% sucrose in PBS at room temperature for 15 minutes. After two washes with PBS, cells were permeabilized with 0.01% Triton-X-100 for 10 minutes and washed 3x with PBS. After blocking in PBS + 3% BSA for 30 min, cells were incubated in primary antibody in blocking solution overnight at room temperature. Cells were then washed 3x with PBS and incubated with Alexa-fluor conjugated secondary antibodies (Molecular Probes) for 2 h. Cells were then washed 3x with PBS and then mounted with mounting medium containing DAPI (Vector Laboratories). Cells were imaged on a Nikon A1 Laser Scanning Confocal Microscope. Primary antibodies used in this study include rat anti-HA (Sigma; 1:500 dilution), mouse anti-GRA2 (BioVision; 1:1000 dilution), mouse anti-GRA6 (gift of David Sibley; 1:1000 dilution), rabbit anti-ROP2 (1:10,000 dilution).
Protein purification -BPK1 (residues 61-377 cloned into pGEX4T) was expressed as a GST fusion in E. coli Rosetta2(DE3) overnight at 16°C after induction with 300 mM IPTG. Cells were resuspended in 50 mM Tris 8.0, 200 mM NaCl, 1% Triton-X-100 and 0.2% sodium sarkosyl, lysed by sonication, and centrifuged at 27k rcf for 30 min. GST-fusion protein was affinity purified using glutathione sepharose, which was washed first with PBS containing 1% Triton-X-100, and then without detergent. Protein was eluted by overnight on-bead thrombin cleavage at 4°C overnight. BPK1 was further purified by anion exchange and size exclusion chromatography, where it was flash frozen in 10 mM HEPES, pH 7.0, 100 mM NaCl for storage. Recombinant wild-type and mutant WNG1 (residues 265-591; cloned into pET28) proteins were expressed N-terminally fused with His6-SUMO in E. coli Rosetta2(DE3) incubated overnight at 16°C after induction with 300 mM IPTG. Bacteria were lysed in 50 mM HEPES 7.4, 500 mM NaCl, 15 mM Imidazole, lysed by sonication, and centrifuged as above. His6-fusion proteins were affinity purified using NiNTA resin, and eluted in 50 mM Tris, pH 7.0, 500 mM 11   377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408  409  410  411  412  413  414  415  416  417  418  419 NaCl, 250 mM imidazole and dialyzed in 20 mM Tris, pH 7.0, 300 mM NaCl before concentration and flash freezing for long-term storage.
Protein crystallization -Small hexagonal plates of BPK1 grew in a wide variety of conditions in initial screens. High quality crystals were seeded from initial hits grown in 0.2M Proline, 0.1M HEPES 7.4, 10% PEG-3350. To generate a platinum derivative, crystals were soaked with reservoir solution containing 10 mM K2PtCl4 for 2 h and washed quickly in reservoir solution. All crystals were flash frozen in a cryoprotectant of reservoir with 25% ethylene glycol.
Data collection, structure determination, and refinement -The diffraction data for the native crystals were collected at beamline 19-ID at the Advanced Photon Source at a wavelength of 1.038 Å and a temperature of 100 K. Native crystals diffracted to 2.5 Å, though diffraction was highly anisotropic, ranging from 2.2 Å in the best dimension to 2.8 Å in the worst. Data for the platinum dervatives were collected in an inverse beam experiment at 1.07195 Å, 1.076276 Å, and 1.07229 Å, corresponding to peak, remote, and inflection wavelengths. Integration, indexing, and scaling of the diffraction data were performed using the HKL2000 suite of programs (72) . Initial phases at 3.5 Å were determined by multiwavelength anomalous diffraction from the Pt datasets using the SHELX suite (73) and used to generate a starting model after density modification with the SOLVE/RESOLVE package (74, 75) . The high resolution native data were incorporated for extension and map improvement in Phenix (76) . Manual rebuilding in Coot (77) and refinement in Refmac5 (78), led to a final 2.5 Å structure of BPK1 (PDB accession: 6M7Z). The structure was evaluated with Molprobity (79) .
Homology modeling -A model of the WNG1/ROP35 structure was created in Modeller v9.14 (80) using the BPK1 structure as a template and an alignment of BPK1 and WNG1 created using Clustal Omega (81) .
In vitro kinase assays -The kinase assays comparing WT and mutant activities were run using 2 µM of His6sumo-WNG1, 4 mM MgCl2, 200 µM cold ATP, 1mM DTT, 1mg/mL BSA, 10% glycerol, 300 mM NaCl, 20 mM Hepes pH 7.5. Reactions were started by adding a hot ATP mix, that contained 10 µCi ɣ[ 32 P] ATP and 5 µg MBP. The KM,ATP kinase assays were run using the same mix as above except non-radioactive ATP was used in a range of concentrations from 1 mM to 32.5 µM. The 25 µL reactions were incubated at a 30°C water bath for 2 h. Reactions were stopped by adding 9 µL 4x SDS-buffer. 20 µL samples were then run on an SDS-PAGE gel. The gels were coomassie stained, the MBP band, excised and radioactivity quantified using a scintillation counter. All data were analyzed using GraphPad Prism 7.
Cell culture, lysis and protein digestion for MS proteomics -All reagents were obtained from Sigma-Aldrich unless specified otherwise. Parental (WT) and RHΔwng1 Toxoplasma parasites were cultured in either R0K0 (light) or R10K8 (heavy) SILAC medium (Dundee Cell Products) for 8 generations to ensure efficient heavy label incorporation. 24 h prior cell lysis human foreskin fibroblasts (HFFs) were infected (MOI=5) with WT or RHΔwng1 parasites. Lysis was then performed in 8 M urea, 75 mM NaCl, 50mM Tris, pH=8.2, supplemented with protease (complete mini tablets, Roche) and phosphatase (Phos Stop tablets, Roche) inhibitors followed by sonication to reduce sample viscosity (30 % duty cycle, 3 × 30 sec bursts, on ice). Protein concentration was measured using BCA protein assay kit (Thermo Fisher Scientific) and equal amounts of heavy and light lysates mixed in 1:1 ratio. Lysates were subsequently reduced with 5 mM dithiothreitol (DTT) for 30 min at room temperature and alkylated with 14 mM iodoacetamide for 30 min at room temperature in the dark. Following quenching with 5 mM DTT for 15 min in the dark lysates were diluted with 50 mM ammonium bicarbonate to reduce the concentration of urea to < 2M and digested with trypsin (Promega) overnight at 37 ⁰C. After digestion samples were acidified with trifluoroacetic acid (TFA) (Thermo Fisher Scientific) to a final concentration of 1 % (v/v), all insoluble material was removed by centrifugation and the supernatant was desalted with Sep-Pak C18 cartridges (Waters). The samples were further digested with LysC (Promega) for 2-3 h at 37 ⁰C and trypsin overnight at 37 ⁰C followed by desalting with Sep-Pak as above.
Phosphopeptide enrichment -Desalted and vacuum dried samples were solubilized in 1 ml of loading buffer (80 % acetonitrile, 5 % TFA, 1 M glycolic acid) and mixed with 5 mg of TiO2 beads (Titansphere, 5 µm GL Sciences Japan). Samples were incubated for 10 min with agitation followed by a 1 min 2000 × g spin to pellet the beads. The supernatant containing all non-phosphorylated peptides (total proteome) was removed and stored at -80 ⁰C. The beads were washed with 150 μl of loading buffer followed by two additional wash steps, first with 150 μl 80 % acetonitrile, 1 % TFA and second with identical volume of 10 % acetonitrile, 0.2 % TFA. After each wash beads were pelleted by centrifugation (1 min at 2000 × g) and the supernatant discarded. The beads were dried in a vacuum centrifuge for 30 min followed by two elution steps at high pH. For the first elution step the beads were mixed with 100 μl of 1 % ammonium hydroxide (v/v) and for the second elution step with 100 µl of 5 % ammonium hydroxide (v/v). Each time the beads were incubated for 10 min with agitation and pelleted at 2000 × g for 1 min. The two elutions were combined and vacuum dried.
Mass spectrometry sample fractionation and desalting -Both phospho-and total proteome (40 μg) samples were fractionated in a stage tip using Empore SDB-RPS discs (3M). Briefly, each stage tip was packed with one high performance extraction disc, samples were loaded in 100 μL of 1 % TFA, washed with 150 μL of 0.2 % TFA and eluted into 3 fractions with 100 μL of the following: 1) 100 mM ammonium formate, 20 % acetonitrile, 0.5 % formic acid; 2) 200 mM ammonium formate, 40 % acetonitrile, 0.5 % formic acid; 3) 5 % ammonium hydroxide, 60 % acetonitrile. The fractions were taken to dryness by vacuum centrifugation and further desalted on a stage tip using Empore C18 discs (3M). Briefly, each stage tip was packed with one C18 disc, conditioned with 100 µl of 100 % methanol, followed by 200 µl of 1 % TFA. The sample was loaded in 100 μL of 1 % TFA, washed 3 times with 200 µl of 1 % TFA and eluted with 50 µl of 50 % acetonitrile, 5 % TFA. The desalted peptides were vacuum dried in preparation for LC-MS/MS analysis.
nLC-MS/MS and data processing -Samples were resuspended in 0.1 % TFA and loaded on a 50 cm Easy Spray PepMap column (75 μm inner diameter, 2 μm particle size, ThermoFisher Scientific) equipped with an integrated electrospray emitter. Reverse phase chromatography was performed using the RSLC nano U3000 (Thermo Fisher Scientific) with a binary buffer system (solvent A: 0.1% formic acid, 5% DMSO; solvent B: 80% acetonitrile, 0.1% formic acid, 5% DMSO) at a flow rate of 250 nl/min. The samples were run on a linear gradient of 2-35% B in 90 or 155 min with a total run time of 120 or 180 min, respectively, including column conditioning. The nanoLC was coupled to a Q Exactive mass spectrometer using an EasySpray nano source (Thermo Fisher Scientific). The Q Exactive was operated in data-dependent mode acquiring HCD MS/MS scans (R=17,500) after an MS1 scan (R=70, 000) on the 10 most abundant ions using MS1 target of 1 × 106 ions, and MS2 target of 5 × 104 ions. The maximum ion injection time utilized for MS2 scans was 120 ms, the HCD normalized collision energy was set at 28, the dynamic exclusion was set at 20 or 30 s for 120 and 180 min runs, respectively, and the peptide match and isotope exclusion functions were enabled. Raw data files were processed with MaxQuant (82) (version 1.5.0.25) and peptides were identified from the MS/MS spectra searched against Toxoplasma gondii proteome (ToxoDB, 2017) using Andromeda (83) search engine. SILAC based experiments in MaxQuant were performed using the built-in quantification algorithm (82) with minimal ratio count = 1, enabled 'Match between runs' option for fractionated samples (time window 0.7 min) and 'Re-quantify' feature. Cysteine carbamidomethylation was selected as a fixed modification whereas methionine oxidation, acetylation of protein N-terminus and phosphorylation (S, T, Y) as variable modifications. The enzyme specificity was set to trypsin with maximum of 2 missed cleavages. The precursor mass tolerance was set to 20 ppm for the first search (used for mass re-calibration) and to 4.5 ppm for the main search. The datasets were filtered on posterior error probability to achieve 1% false discovery rate on protein, peptide and site level. "Unique and razor peptides" mode was selected to allow identification and quantification of proteins in groups (razor peptides are uniquely assigned to protein groups and not to individual proteins). Data were further analyzed as described in the Results section and in the Supplementary Table S4 using Microsoft Office Excel 2010 and Perseus (84) (version 1.5.0.9).
Fractionation of PV membranes -Highly infected monolayers of HFFs were rinsed twice with phosphate buffered saline (PBS) and harvested. PBS containing 1 mM EDTA with protease inhibitors were added to the cells, and cells were mechanically disrupted by passage through a 27 g needle. Proteins secreted in the PV were separated by a low speed (2500 g) spin, and the resulting supernatant (LSS) was further separated by ultracentrifugation at 50,000 rpm for 2 hours at 4 °C using TL100 rotor. The supernatant was aspirated as soluble fraction while the pellet was re-suspended in the same volume buffer. Equal volumes of each fraction were loaded on SDS-PAGE for analysis by western blot, which were quantified in ImageJ (85) .
Triton-X-114 partitioning -The LSS fraction of infected monolayers was prepared as above, and further partitioned using a protocol modified as follows from (54) . Pre-condensed Triton-X-114 was added to the LSS to make the final concentration of 2% Triton-X-114. After a few minutes incubation on ice, the solution was warmed at 30°C for 3 minutes, then centrifuged for 5 minutes at 4000 rpm at room temperature. The top aqueous layer was collected in another tube, and added the same volume of 10 mM Tris-HCl pH7.4, 150 mM NaCl with protease inhibitors. The cleared solution after placed in 0°C for a few minutes was warmed at 30 °C again, and centrifuged again. The aqueous layer was separated from the detergent enriched fraction. After separation, Triton-X-114 and buffer were added, respectively, to the aqueous and detergent phases in order to obtain equal volumes and approximately the same salt and surfactant content for both samples.
Western blotting -Proteins were separated by SDS-PAGE and transferred to a PVDF membrane. Membranes were blocked for 1 hour in TBST + 3% milk, followed by overnight incubation at 4°C with primary antibody in blocking solution. The next day, membranes were washed 3× with TBST, followed by incubation at room temperature for 1-2 hours with HRP-conjugated secondary antibody (Sigma) in blocking buffer. After 3× washes with TBST, western blots were imaged using ECL Plus reagent (Pierce) on a GE ImageQuant LAS4000. Antibodies used in this study include: mouse anti-GRA1 (BioVision; 1:1,000 dilution), mouse anti-GRA2 (BioVision; 1:1,000 dilution), mouse anti-GRA3 (gift of J-F Dubremetz; 1:2,000 dilution), mouse anti-GRA4 (gift of LD Sibley; 1:10,000 dilution), mouse anti-GRA5 (BioVision; 1:1,000 dilution), mouse anti-GRA6 (gift of LD Sibley; 1:10,000 dilution), rabbit anti-GRA7 (gift of LD Sibley; 1:10,000 dilution), rabbit anti-ROP2 (1:10,000 dilution), rat anti-HA (Sigma; 1:500 dilution).
Transmission electron microscopy -Cells were fixed on MatTek dishes with 2.5% (v/v) 14   506  507  508  509  510  511  512  513  514  515  516  517  518  519  520  521  522  523  524  525  526  527  528  529  530  531  532  533  534  535  536  537  538  539  540  541  542  543  544  545 546 547 glutaraldehyde in 0.1M sodium cacodylate buffer. After three rinses in 0.1 M sodium cacodylate buffer, they were post-fixed with 1% osmium tetroxide and 0.8 % K3[Fe(CN6)] in 0.1 M sodium cacodylate buffer for 1 h at room temperature. Cells were rinsed with water and en bloc stained with 2% aqueous uranyl acetate overnight. After three rinses with water, specimens were dehydrated with increasing concentration of ethanol, infiltrated with Embed-812 resin and polymerized in a 70ºC oven overnight. Blocks were sectioned with a diamond knife (Diatome) on a Leica Ultracut UC7 ultramicrotome (Leica Microsystems) and collected onto copper grids, post stained with 2% Uranyl acetate in water and lead citrate. Images were acquired on a Tecnai G2 spirit transmission electron microscope (FEI) equipped with a LaB6 source at 120 kV. Images were analyzed and quantified using the Fiji distribution of ImageJ (85) . Figure generation -Structural models were generated using PyMOL v1.7 (86) . Secondary structure cartoons in Figure 3 were generated using the Pro-origami web server (87) . Data plotting and statistical analyses were conducted in Graphpad Prism v7.02. All figures were created in Inkscape v0.91. 
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Supplemental Figure S1b
Figure S1b: Alignment of the N-lobes of human PKA and Toxoplasma gondii WNG kinase domains. Secondary structure elements from the PKA crystal structure (1ATP) are indicated as cartoons above the alignment. The PKA Gly-loop is boxed in red. Note that the WNG kinases lack sequences corresponding to the Gly-loop, which has been replaced with a conserved sequence predicted to form helices. T   271  106  396  60   TgWNG1  TgWNG2  TgWNG3  TgBPK1   377  219  528 169 Table S1c : Gene models (for sequences in ToxoDB) or NCBI accession numbers of sequences used in this study. Supplemental Table  S10 . Supplementary Table 5 for full data set. Significantly changing phosphosites (p-value < 0.05 and -1 > log2 change > 1) enriched in dense granule proteins are highlighted. GKGEH T PPLPD TGGT1_203310 GRA3 S120
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Supplemental Figure S5b
KVEEL S LLRRR PV/IVN membrane (53) TGGT1_286450 GRA5 S108* EESKE S ATAEE ERSHA S EDEDD TGGT1_267740 GRA45 S186** EAELI S LSPGG PV/IVN (this study) * Not significant in t-test due to variability between replicates (p>0.05) or quantified in only one type of labeling (Rv samples only) ** Identified in preliminary dataset, not statistically significant in final data Table 2 : Phosphosites lost in RHΔwng1 vacuoles. The sequence context of each of the phosphosites is indicated. Acidic residues are red, basic residues are blue. Note that some regions appear to be hyperphosphorylated in a WNG1-dependent manner. Such potential priming sites are indicated bolded with a gray background in the phosphosite context. Within the parasite secretory pathway, membrane-seeking GRA proteins (blue, green, and gray cylinders) are complexed with solubilizing proteins or domains (orange). Once secreted into the PV lumen, WNG1 is activated through an unknown mechanism and phosphorylates the GRAs, leading to their eventual insertion into the PV membrane and efficient stabilization of the IVN tubules.
